The APL-like flow cytometry profile was reported in 30–50% of NPM1-mutated AML [160,161] (more common in the case of co-mutations of TET2/IDH1/IDH2 genes [160]) and 8% of KMT2A-rearranged AML [162]. The gene discussed is TET2; the disease is acute myeloid leukemia.